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In 1820, French naturalist August Saint Hillaire, during a visit in Espírito Santo (ES), a state in southeastern 
Brazil, reported a popular use of Cyperaceae species as antidote to snake bites. The plant may even have 
a hypotensive effect, though it was never properly researched. The in vitro inhibitory of the angiotensin 
converting enzyme (ACE) activity of eigth ethanolic extracts of Cyperaceae was evaluated by colorimetric 
assay. Total phenolic and flavonoids were determined using colorimetric assay. The hypotensive effect of 
the active specie (Rhychonospora exaltata, ERE) and the in vivo ACE assay was measured in vivo using 
male Wistar Kyoto (ERE, 0.01-100mg/kg), with acetylcholine (ACh) as positive control (5 µg/kg, i.v.).  
The evaluation of ACE in vivo inhibitory effect was performed comparing the mean arterial pressure 
before and after ERE (10 mg/kg) in animals which received injection of angiotensin I (ANG I; 0,03, 03 and 
300 µg/kg, i.v.). Captopril (30 mg/kg) was used as positive control. Bulbostylis capillaris (86.89 ± 15.20%) 
and ERE (74.89 ± 11.95%, ERE) were considered active in the in vitro ACE inhibition assay, at  
100 µg/mL concentration. ACh lead to a hypotensive effect before and after ERE’s curve (-40±5% 
and -41±3%). ERE showed a dose-dependent hypotensive effect and a in vivo ACE inhibitory effect. 
Cyperaceae species showed an inhibitory activity of ACE, in vitro, as well as high content of total phenolic 
and flavonoids. ERE exhibited an inhibitory effect on both in vitro and in vivo ACE. The selection of 
species used in popular medicine as antidotes, along with the in vitro assay of ACE inhibition, might be 
a biomonitoring method for the screening of new medicinal plants with hypotensive properties.
Uniterms: Cyperaceae/species/pharmacognosy. Cyperaceae/species/in vitro inhibitory activity. 
Cyperaceae/species/in vivo hypotensive effect. Angiotensin converting enzyme/in vitro inhibitory. 
Flavonoids/determination.
Em 1820, o naturalista francês August Saint Hillaire, durante uma visita ao Espírito Santo (ES), Estado do 
sudeste do Brasil, relatou o uso popular de espécies de Cyperaceae como antídoto para picadas de cobra. 
As espécies podem possuir efeito hipotensor, embora nunca tenham sido devidamente pesquisadas. A 
inibição in vitro da atividade da enzima conversora da angiotensina (ECA) de oito extratos etanólicos de 
Cyperaceae foi avaliada por ensaio colorimétrico. Totais de fenólicos e flavonóides foram determinados 
utilizando ensaio colorimétrico. O efeito hipotensor da espécie ativa (Rhychonospora exaltata, ERE) no 
ensaio de ECA in vitro foi avaliada in vivo utilizando-se machos Wistar Kyoto (ERE, 0.01-100 mg/kg),  
com a acetilcolina (ACh), como controle positivo (5 µg/kg, iv). A avaliação do efeito inibidor da ECA 
in vivo foi realizado comparando-se a pressão arterial média, antes e após ERE (10 mg/kg) nos animais 
que receberam injeção de angiotensina I (Ang I, 0,03, 03 e 300 µg/kg, iv). Captopril (30 mg/kg) foi 
utilizado como controle positivo. Bulbostylis capillaris (86,89±15,20%) e ERE (74,89±11,95%, ERE) 
foram considerados ativas no ensaio de inibição da ECA in vitro, na concentração de 100 μg/mL. A 
ACh gerou um efeito hipotensor, antes e depois da curva de ERE (-40 ± 5% -41 ± 3%). ERE apresentou 
efeito hipotensivo dependente da dose e um efeito inibidor da ECA in vivo. As espécies de Cyperaceae 
mostraram uma atividade inibidora de ACE in vitro, bem como elevado conteúdo de substâncias fenólicas 
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e flavonóides. ERE exibiu um efeito inibidor da ECA tanto in vitro como in vivo. A seleção das espécies 
utilizadas na medicina popular como antiofídicos, juntamente com o ensaio in vitro de inibição da ECA, 
pode ser um método de biomonitoramento para a seleção de novas plantas medicinais com propriedades 
hipotensores.
Unitermos: Cyperaceae/espécies/farmacognosia. Cyperaceae/espécies/inibição in vitro. Cyperaceae/
espécies/efeito hipotensor. Enzima conversora de angiotensina/inibição in vitro. Flavonoides/
determinação.
INTRODUCTION
French naturalist August Saint Hillaire, during 
his stay in ES, noted that locals used some Cyperaceae, 
Aristilochiaceae and Fabaceae plants to treat wounds 
caused by snake bites - two of which applied orally 
and the other one applied locally (Saint-Hillaire, 
1820/2002). Regarding the study of antihypertensive 
plants, the selection can be ethnobotanical, based on 
species used as diuretics, antidotes and antihypertensives 
(Ribeiro, et al., 1986). Several species commonly used 
as antivenins also present anti-inflammatory, antioxidant 
and hypotensive activity (Balestrin et al., 2008). Species 
of the Cyperus genus, Cyperaceae family, are reported 
as anti-inflammatory (Falcão, et al., 2005), antimalarial 
(Schwikkard, Heerden, 2002) and hepatoprotective 
extracts (Amani et al., 2012).
Concerning the advanced ecosystem destruction 
together with the potentialities of the Cyperaceae family, 
the aim of this study were to identify whether any of the 
the ethanolic extracts of Cyperaceae species presents an 
inhibitory effect on in vitro ACE, and whether the most 
active species in vitro shows an acute hypotensive effect 
in vivo and ACE inhibitory effect in vivo.
MATERIAL AND METHODS
Plant materials and extraction
Ten specimens from Cyperaceae family were 
harvested (July, 2010) from Paulo César Vinha State 
Park (PEPCV), with the previous approval of local 
environmental authorities (IEMA, protocol 629/09). The 
samples gathered were identified by the botanists Oberdan 
José Pereira and Márcio Lacerda Lopes Martins, and a 
voucher specimens were deposited at the herbarium of 
the Espírito Santo Federal University (UFES, VIES): 
Bulbostylis capillaris (L.) C.B.Clarke (20°36'22.5"S; 
40°25'02.0"W, VIES 26082 and VIES 26085) Cyperus 
tenuis Sw. (20°36'12,8"S; 40°25'27.7"W. VIES 26083), 
Eleocharis intersticta Vahl (20°36'17.6"S; 40°25'16.1"W, 
VIES 26380), Remirea maritima Aubl (20°36'33.2"S; 
40°24'43.7"W, VIES 26379), Rhynchospora exaltata 
Kunth (20°36'22.8"S; 40°25'07.8"W, VIES 26079), 
Rhynchospora holoschoenoides Rich. (20°36'23.1"S; 
40°25'01.09"W, VIES 26086), Rhynchospora tenuis 
Link (20°36'17.1"S; 40°25'2.66"W, VIES 26081 
and VIES 26087), Scleria secans L. (20°36'21.5"S; 
40°25'10.5"W, VIES 26080). Two of the ten collected 
specimens were identified as the same (B. capillaris and 
R. tenuis).
The collected plants were dryed at 40 ºC (48 h) 
and grounded. The ethanolic extract was prepared by 
successive ultrasound-assisted (15 min, 40Hz) extraction. 
The extract was then concentrated using a rotatory-
evaporator at 40 ºC, under low pressure conditions, 
obtaining the crude ethanolic extract of the species: B. 
capillaris (0.16 g), C. tenuis (0.06 g), E. interstinata (0.71 
g), R. exaltata (1.4 g), R. haloschoenoides (0.8 g), R. tenuis 
(0.91 g), R. maiÌtima (0.3 g) and S. secans (2.1 g).
Determination of total phenolic
The total phenolic content was determined using 
Folin-Ciocalteu method, along with some modifications 
(Singleton, Rossi, 1965). Solutions at a concentration 
of 1.5 mg/mL of the ethanolic extracts were prepared. 
The calibration curve was plotted with a pyrogallol 
solution (from 10 to 350 µg/mL), and the equation was 
y = 0.001244x + 0.002889, r2 = 0.9977. The results 
were expressed as micrograms of pyrogallol equivalents 
(PE) per milligram of dry sample. The analyses were 
performed in triplicates. The limit of quantification was 
13.7 µg/mL and the limit of detection was 4.1 µg/mL.
Dtermination of total flavonoids
The total flavonoids content was determined by 
colorimetric aluminum chloride method (Marinova et 
al., 2005). The calibration curve was prepared with rutin 
solutions, at the 31.25-1000 µg/mL range. The calibration 
regression equation was y = 0.0033x + 0.0121, r2=0.9991. 
The results were expressed as micrograms of rutin 
equivalents (RE) per milligram of sample. The analyses 
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were done in triplicates. The limit of quantification was 
5.3 µg/mL and the limit of detection was 1.6 µg/mL.
High performance liquid chromatography (HPLC) 
analysis
The analysis of the eight Cyperaceae extracts, 
especially of ERE by HPLC was performed in a Waters 
1515 separation device, along with a binary pump, and an 
UV/VIS detector (model 2489). The data were processed 
using the Breeze software. A C18 XBridge reverse-phase 
column was used (150 x 4.6 mm i.d., 3.5 µm, Waters), 
along with an also C-18 XBridge precolumn (20 x 4.6 mm 
i.d., 3.5 µm, Waters), at room temperature. Two isocratic 
elution systems were used. The first one was composed by 
a MeOH:H2O (9:1) solution, wavelength detection at 254 
and 365 nm, and isocratic flow at 0.8 mL/min; the second 
was employed a MeOH:H2O:ACN: AcOOH: CHOOH 
(20:10:20:1:1) eluent, same wavelengths, and 1.2 mL/min 
flow. The solvents were HPLC quality (Merck, Darmstadt, 
Germany), the water was ultrapure (ELGA, 18.2Ω) and 
was degassed by sonication and vacuum pump prior 
to use. Both the reference rutin and apigenin solutions 
(Sigma, St. Louis, USA) and the ERE sample were 
dissolved in MeOH, HPLC degree (Merck, Darmstadt, 
Germany). The sample concentration was 1.0 mg/mL. 
The final concentration of the reference solutions used 
on the plotting of the standard curve ranged from 0.03 to 
0.6 µg/mL. Samples, as well as reference solutions, were 
centrifuged at 8400 g for 5 min. Each sample and standard 
solution (20 µL) was done manually. All analyses were 
done in triplicates.
ACE in vitro inhibition assay
Effects of the Cyperaceae crude ethanolic extracts 
on ACE were determined by measuring the accumulation 
of Gly-Gly (glycine-glycine), the ACE cleavage product 
of Hip-Gly-Gly. This assay was performed as previously 
described (Endringer et al., 2014). In brief, the assays 
were initiated by an addition of 10 µL of the sample (final 
concentration of 100 μg/mL), 10 µL of MeOH/HEPES 
(1: 4), pH 8.0 (negative control), or 10 µL of a captopril 
solution (final concentration of 64 nM; positive control) 
into a 96-well plate. A rabbit lung solution (10 µL for 
the final concentration of 9.1 mg/mL) was used as the 
ACE source. The plate was then homogenized and pre-
incubated at 37 °C for 10 min. The enzymatic reaction 
was initiated by an addition of 60 µL of the HEPES buffer 
(final concentration of 27.3 mM), pH 8.15 and 30 µL of a 
Hip-Gly-Gly solution (final concentration of 27.3 mM). 
After the homogenization, the mixture was incubated for 
40 min at 37 °C. The reaction was stopped by an addition 
of 100 µL of 0.3 M sodium tungstate and 100 µL of 0.3 M 
sulfuric acid. In the sequence, an aliquot (64 µL) was 
diluted with 100 µL of water and kept in rest for 5 min. 
Subsequently, the system was mixed with the color 
reagent 2,4,6trinitrobenzenesulfonic acid solution, TNBS 
(6.92 mM) (Sigma, USA). The plate was kept in the dark 
at room temperature for 20 min and its absorbance was 
measured using a microplate reader (BioRad, Model 550) 
at 415 nm. The readings were compared against a blank 
solution, which was prepared in a similar manner with the 
exception of sodium tungstate and sulfuric acid solutions 
being added before the rabbit lung solution. Based on the 
measured ACE inhibitory activity, the compounds were 
classified as inactive (<30 %), weak (>30 % to 50 %), 
moderate (>50 % to 80%), and strong (>80 %) inhibitors.
Acute hypotensive assay
The in vivo experiments were performed according 
to the ethical principles determined by Brazilian School 
of Animal Experimentation (COBEA, 1991), and were 
approved by the Ethical, Bioethical and Animal Welfare 
Committee (CEUA - UVV, 120/2010). Male Wistar Kyoto 
(WKY; n=6) and Spontaneously Hypertensive Rats (SHR; 
n=6) were used. The animals were about three months old, 
with a body weight from 200 to 250 g. The rats were kept 
at temperatures of 22 ± 3 ºC, in a 12 h light/12 h dark cycle, 
and had free access to standard pellet diet (Probiotério 
stockfeed, Moinho Primor SA) and water.
Under sodium pentobarbital anesthetic (50 mg/kg, 
intraperitonial Hypnol, Crystal, Brasil) (Andrade et al., 
2008), both femoral arteries and veins were catheterized 
(polyethylene catheter, PE 50, Clay Adans, USA). The 
venous catheter was used for the injection of the raw 
ethanolic extract from R. exaltata (ERE - 267 mg/mL 
in saline solution) and/or saline, the arterial catheter 
was connected to pressure pipes (Spectramed, Statham, 
P23XL, USA) by a flexible catheter, and the register values 
of the mean arterial pressure (MAP) were collected by a 
computer (Pentium MMX 233 MHz) and by a biological 
data acquisition software (Biopac, Biopac Systems, USA, 
mod. 100A/94111065 MP series).
The acute hypotensive effect was evaluated by 
the plotting of a dose-effect curve of the ERE solution. 
The WKY and SHR animals received saline 1 mL/kg 
(Soncini et al., 2011) and, afterwards, increasing doses, in 
bolus, of ERE (0.01 – 100 mg/kg). The subsequent dose 
was administrated only after MAP returned to the levels 
observed prior to the first application. ACh was utilized as 
M. L. L. Martins, H. P. Pacheco, I. G. Perini, D. Lenz, T. U. Andrade, D. C. Endringer806
positive control (5 µg/kg, i.v.;) both before and after the 
ERE curve (Lahlou et al., 2003).
ACE in vivo inhibition assay
ACE in vivo inhibitory evaluation was performed 
according to Mangiapane et al. (1994), with slight 
modifications. Briefly, the effect of angiotensin I (ANGI; 
0.03, 03 and 300 µg/kg i.v.) was analyzed before and 
after the injection of a single dose of ERE ethanolic 
extract (10 mg/kg, i.v.). As positive control, ANG I was 
administered before and after captopril (30 mg/kg).
Statistical analysis
The values of the biological evaluation were 
expressed as the mean ± standard error of the mean 
(S.E.M.). Basic values of MAP and FC, and MAP after 
ERE’s injection were submitted to analysis of variance 
(ANOVA), followed by a post-hoc Fisher test, p<0.05. 
Correlation coefficient of the standard curves was obtained 
by linear regression by the least squares method and the 
data were then analyzed by ANOVA, on a 95% LC and 
degree of freedom of n-1. The limits of detection (LOD) 
and quantification (LOQ) were computed by the division 
of the standard deviation of the slope of the curves on the 
calibration assay.
RESULTS AND DISCUSSION
There are just a few taxonomical studies about the 
Cyperaceae family, which makes it hard to identify and/
or differentiate the species (Martins et al., 1999). From 
the gathered Cyperaceae specimens, two of them were of 
the same species (B. capillaris and R. tenuis), and one of 
them (B. capillaris) is on August de Saint-Hillaire Virtual 
Herbarium species list (Virtual Herbarium, 2012). B. 
capillaris as well as R. exaltata were considered active 
on the ACE inhibition assay (Table I).
The 50% inhibitory in vitro ACE concentration 
(CI50) of the active species could not be calculated, as 
the observed inhibitory effect was dose-independent. 
The presence of total polyphenols, including tannins, on 
the extracts might be related to this not specific in vitro 
inhibition. Nyman et al. (1998), observed that only four 
species, from the thirteen considered active in the ACE 
assay, remained presenting dose-dependent inhibitory 
ACE activity after tannins were removed. Polyphenols, 
distinctly from flavonoids, might be related to the 
inhibitory ACE activity of B. capillaris species.
However, it is not possible to establish a correlation 
between the in vitro ACE inhibition percentage and 
the content of total phenolics, as they might be the 
constituents related to the ACE inhibitory effect noted 
for R. exaltata (table I). Barbosa-Filho et al. (2006), 
summarized several studies of the natural products with 
inhibitory ACE activity and observed that flavonoids 
and tannins were related to the activity of several species 
among them: Erythroxylum laurifolium, “Korean” 
green tea, Allophylus edulis. In the present study, C. 
rotundus, Cyperaceae, was cited, but it did not show ACE 
inhibition (Barbosa-Filho et al., 2006).
The two species showing the most effective ACE 
inhibition were B. cappilaris and R. exaltata. Due to the 
available amount of active samples, R. exaltata was chosen 
for the in vivo hypotensive study. The chromatographic 
profile obtained for ERE was simple, on the analyzed 
wavelengths, with a dominance of polar substances, 
TABLE I - ACE inhibition percentages, total polyphenols and flavonoids amounts for the analyzed Cyperaceae species
% ACEIa Total polyphenolsb Total flavonoidsc
Captopril 73.2 ± 20.0
Bulbostylis capillaries 86.9 ± 15.2 141.0 ± 16.1 11.0 ± 3.6
Cyperus tenuisd NA NA NA
Eleocharis interstincta 30.7 ± 7,8 30.1 ± 1.9 31.2 ± 5.0
Remiria maritime NA 92.4 ± 3.4 34.3 ± 2.1
Rhynchospora exaltata 74.9 ± 12.0 36.7 ± 4.9 125.8 ± 2.9
Rhynchospora tenuis 50.4 ± 23.2 163.5 ± 18.3 149.2 ± 9.0
Rhynchospora haloschoenoides NA 51.3 ± 3.6 90.8 ± 5.3
Scleria secans 26.5 ± 4.6 194.7 ± 19.9 93.9 ± 2.4
aInhibition percentage of ACE. bResults presented as micrograms of pyrogallol equivalents per milligram of sample. cResults 
presented as micrograms of rutin equivalents per milligram of sample. dNA: not evaluated due to the available mass.
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suggesting the presence flavonoid-like compounds. Using 
particular flavonoid eluents, in comparison with rutin and 
apigenin, peaks related to aglycones, but an overlap of 
peaks related to glycolized flavonoids (rutin and others).
As expected MAP of SHR (182±8 mmHg; p<0.01) 
animals was higher compared with WKY (99±5 mmHg). 
During the acute hypotensive assay, the ethanolic 
crude extract of R. exaltata determined a reduction of 
the pressure levels in a dose-dependent way in both 
normotensive and hypertensive animals (Figure 1), which 
were statistically different from the reduction caused 
by the saline injection (WKY: -7.6±3 mmHg; SHR: 
-8±4 mmHg). Reductions elicited in SHR animals were 
greater compared with WKY (Figure 1). ACh induced a 
hypotensive effect before and after ERE’s curve (WKY: 
-43.2±4 mmHg and -44.3±3 mmHg; SHR: -74±5 mmHg 
and -78 mmHg; p<0.01 compared with WKY), suggesting 
vascular integrity, as the vascular relaxation induced by 
ACh is dependent on the integrity of endothelial cells 
(Batlouni, 2001). The in vivo ACE inhibition of ERE is 
reported in Table II. ANGI at all tested doses (0.03, 3.0, 
300.00 µg/kg) increased the MAP (Table II, before CAP 
and before ERE). ERE decreased around 50% of the 
ANGI effect (Table II), indicating that ERE inhibits ACE 
in vivo. However, the design of the in vivo inhibition assay 
applied in the present study does not differ between the 
two ACE isoforms and also not between AngII and its 
metabolite, Ang 1-7. ACE and ACE2 isoforms are 40% 
similar (Watermeyer et al., 2006; Sturrock et al., 2004). 
ACE2 acts as a carboxylpeptidase, whereas ACE acts as 
a peptidylpeptidase (Brown, Hall, 2005). Several studies 
indicate that both enzymes, ACE and ACE2, have similar 
catalytic mechanisms. However, the ACE inhibitory 
agents, such as captopril, lisinopril, are inactive against 
ACE2. These data suggest that the proteolytic activity of 
ACE2 is different from the isoform ACE. Unlike ACE, 
FIGURE 1 - ERE-induced dose-dependent reduction in 
Mean Arterial Pressure (MAP) in normotensive (WKY) 
and hypertensive (SHR) animals. ERE: ethanolic extract of 
Rhynchospora exaltata. The values are presented as the mean 
± S.E.M. ** p<0.01 compared WKY.
TABLE II - Mean arterial pressure (MAP) increase induced by the injection of ANG I (0.03, 3 and 300 µg/kg, i.v.) before and after 
injection of the ethanolic extract of Rhynchospora exaltata (ERE; 10 mg/kg) and captopril (CAP; 30 mg/kg, triangles)
Groups
ANG I (µg/kg)
0.03 3.0 300
MAPB MAPA ΔMAP MAPB MAPA ΔMAP MAPB MAPA ΔMAP
Before CAP 96±4 126±5 32±4 98±3 153±6 56±4 92±5 190±8 104±6
After CAP 94±3 99±4** 4±2** 93±4 101±3** 8±3** 91±6 105±5** 12±4**
Before ERE 92±4 124±6 34±5 95±3 146±5 49±6 93±4 192±7 100±8
After ERE 95±2 108±3** 14±4**++ 96±5 124±4**+ 31±5**++ 92±4 143±6**++ 53±5**++
MAPB: MAP before ANG I injection; MAPA: MAP after ANG I injection; ΔMAP: difference between MAPA and MAPB. The values 
are presented as the mean ± S.E.M. ** p<0.01 compared with MAP values before CAP or ERE administration. ++ p<0.01 compared 
with MAP after CAP administration.
ACE2 is the monopeptidilcarboxipeptidase (Guy et al., 
2003; Warner et al., 2004; Guy et al., 2005).
Some species analyzed applying a similar assay 
used in the present study also showed hypotensive 
activity (Singi et al., 2005; Soncini et al., 2011). 
Soncini et al. (2011) reported that aqueous extract of 
Averrhoa carambola L. (Oxalidaceae) showed a dose-
dependent pressure reduction. The hypotensive activity 
M. L. L. Martins, H. P. Pacheco, I. G. Perini, D. Lenz, T. U. Andrade, D. C. Endringer808
of hydroalcoholic extracts of garlic (Allium sativum L.) 
and lemon-grass (Cymbopogon citratus (DC) Stapf) were 
reported by Singi et al. (2005).
The data reported in the present study indicate that 
some Cyparaceae species have ACE in vitro inhibitory 
activity, being related with the high content of total 
flavonoids and phenolics. ERE exhibited an inhibitory 
effect on both in vitro and in vivo ACE. The selection 
of species used in popular medicine as antidotes, along 
with the in vitro assay of ACE inhibition, might be a 
biomonitoring method for the screening of new medicinal 
plants with hypotensive properties.
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